Figure 2.
Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load between the day of monoclonal antibody perfusion (day 0) and 7 days after (day 7) in patients treated with (A) casirivimab-imdevimab and (B) sotrovimab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.